Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jun 8, 2023. (Total: 217765Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 8 (of 8 Records)

Query Trace: Leukemia and MLLT3[original query]
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood 2010 Nov 116 (18): 3622-6.
Whitman Susan P, Maharry Kati, Radmacher Michael D, Becker Heiko, Mrózek Krzysztof, Margeson Dean, Holland Kelsi B, Wu Yue-Zhong, Schwind Sebastian, Metzeler Klaus H, Wen Jing, Baer Maria R, Powell Bayard L, Carter Thomas H, Kolitz Jonathan E, Wetzler Meir, Moore Joseph O, Stone Richard M, Carroll Andrew J, Larson Richard A, Caligiuri Michael A, Marcucci Guido, Bloomfield Clara
ARID5B polymorphism confers an increased risk to acquire specific MLL rearrangements in early childhood leukemia.
BMC cancer 2014 14 (1): 127.
Emerenciano Mariana, Barbosa Thayana Conceição, Lopes Bruno Almeida, Blunck Caroline Barbieri, Faro Alessandra, Andrade Camilla, Meyer Claus, Marschalek Rolf, Pombo-de-Oliveira Maria S,
Molecular studies reveal MLL-MLLT10/AF10 and ARID5B-MLL gene fusions displaced in a case of infantile acute lymphoblastic leukemia with complex karyotype.
Oncology letters 2017 8 14 (2): 2295-2299.
Hiwatari Mitsuteru, Seki Masafumi, Akahoshi Shogo, Yoshida Kenichi, Miyano Satoru, Shiraishi Yuichi, Tanaka Hiroko, Chiba Kenichi, Ogawa Seishi, Takita Jun
MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression.
European journal of haematology 2018 2 100 (5): 436-443.
Burillo-Sanz Sergio, Morales-Camacho Rosario M, Caballero-Velázquez Teresa, Carrillo Estrella, Sánchez Javier, Pérez-López Olga, Pérez de Soto Inmaculada, González Campos José, Prats-Martín Concepción, Bernal Ricardo, Vargas María Tere
Fusion partner-specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML.
Blood advances 2020 9 4 (19): 4623-4631.
Matsuo Hidemasa, Yoshida Kenichi, Nakatani Kana, Harata Yutarou, Higashitani Moe, Ito Yuri, Kamikubo Yasuhiko, Shiozawa Yusuke, Shiraishi Yuichi, Chiba Kenichi, Tanaka Hiroko, Okada Ai, Nannya Yasuhito, Takeda June, Ueno Hiroo, Kiyokawa Nobutaka, Tomizawa Daisuke, Taga Takashi, Tawa Akio, Miyano Satoru, Meggendorfer Manja, Haferlach Claudia, Ogawa Seishi, Adachi Souic
Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A.
Proceedings of the National Academy of Sciences of the United States of America 2020 10 117 (42): 26340-26346.
Bill Marius, Mrózek Krzysztof, Kohlschmidt Jessica, Eisfeld Ann-Kathrin, Walker Christopher J, Nicolet Deedra, Papaioannou Dimitrios, Blachly James S, Orwick Shelley, Carroll Andrew J, Kolitz Jonathan E, Powell Bayard L, Stone Richard M, de la Chapelle Albert, Byrd John C, Bloomfield Clara
Novel combined variants of WT1 and TET2 in a refractory and recurrent AML patient.
BMC medical genomics 2021 (1): 158.
Ma Qiang, Guo Yixian, Lan Xiaoxi, Wang Guoxiang, Sun Wanli
Pediatric blastic plasmacytoid dendritic cell neoplasm: report of four cases and review of literature.
International journal of hematology 2021 1 113 (5): 751-759.
Liao Chan, Hu Nan-Xia, Song Hua, Zhang Jing-Ying, Shen Di-Ying, Xu Xiao-Jun, Tang Yong-M
TOP